| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.78M | - | |
| CEO | 338.1K | $2.58M | - | |
| Other | 240.7K | $1.84M | - | |
| Other | 240.3K | $1.83M | - | |
| CFO | 147.1K | $1.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2018 | Stephen Yoo | Chief Medical Officer | Sale+OE | 20,414 | $59.53 | $1,215,344.25 | - | |
| Nov 16, 2018 | Curran Simpson64 | SVP, Technical Operations | Sale+OE | 32,882 | $63.76 | $2,096,418.51 | -45.4% | |
| Nov 15, 2018 | Vittal Vasista79 | Chief Financial Officer | Sell | 7,500 | $60.29 | $452,206.06 | -5.5% | |
| Nov 12, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 20,000 | $63.11 | $1,262,261.20 | -6.5% | |
| Nov 7, 2018 | Patrick J. Christmas | SVP, General Counsel | Sell | 15,000 | $72.06 | $1,080,900.00 | -84.9% | |
| Nov 5, 2018 | Stephen Yoo | Chief Medical Officer | Sale+OE | 20,414 | $68.28 | $1,393,932.53 | - | |
| Nov 5, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 20,000 | $68.25 | $1,364,902.09 | -6.1% | |
| Nov 2, 2018 | Vittal Vasista79 | Chief Financial Officer | Sale+OE | 73,418 | $70.20 | $5,154,019.74 | -34.8% | |
| Oct 29, 2018 | Stephen Yoo | Chief Medical Officer | Sale+OE | 20,414 | $62.37 | $1,273,211.86 | - | |
| Oct 18, 2018 | Patrick J. Christmas | SVP, General Counsel | Sale+OE | 5,000 | $61.78 | $308,890.30 | -22.1% |